Drug Shortage Report for M-RANITIDINE

Last updated on 2021-07-30 History
Report ID 127450
Drug Identification Number 02473534
Brand name M-RANITIDINE
Common or Proper name M-Ranitidine
Company Name MANTRA PHARMA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-10-28
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-07-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1000 RUE DU LUX SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v47 2021-07-30 French Compare
v46 2021-07-30 English Compare
v45 2021-07-23 French Compare
v44 2021-07-23 English Compare
v43 2021-07-16 French Compare
v42 2021-07-16 English Compare
v41 2021-07-09 French Compare
v40 2021-07-09 English Compare
v39 2021-07-02 French Compare
v38 2021-07-02 English Compare
v37 2021-06-23 French Compare
v36 2021-06-23 English Compare
v35 2021-06-18 French Compare
v34 2021-06-18 English Compare
v33 2021-06-11 French Compare
v32 2021-06-11 English Compare
v31 2021-06-04 French Compare
v30 2021-06-04 English Compare
v29 2021-05-28 French Compare
v28 2021-05-28 English Compare

Showing 1 to 20 of 47